These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27461582)

  • 1. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
    Midha S; Chawla S; Garg PK
    Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
    Becker AE; Hernandez YG; Frucht H; Lucas AL
    World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
    Pang Y; Holmes MV; Chen Z; Kartsonaki C
    J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
    Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Cancer: A Review.
    Yabar CS; Winter JM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):429-45. PubMed ID: 27546841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
    Yeo TP
    Semin Oncol; 2015 Feb; 42(1):8-18. PubMed ID: 25726048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial pancreatic cancer.
    Rieder H; Bartsch DK
    Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Pancreatic Ductal Adenocarcinoma.
    Diaz KE; Lucas AL
    Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
    Andersen DK; Korc M; Petersen GM; Eibl G; Li D; Rickels MR; Chari ST; Abbruzzese JL
    Diabetes; 2017 May; 66(5):1103-1110. PubMed ID: 28507210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with pancreatic cancer in Spain. What can we learn from epidemiological studies?
    Marra-López Valenciano C
    Rev Esp Enferm Dig; 2022 Aug; 114(8):445-447. PubMed ID: 35704373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients.
    Korpela T; Udd M; Mustonen H; Ristimäki A; Haglund C; Seppänen H; Kylänpää L
    Int J Cancer; 2020 Sep; 147(5):1450-1460. PubMed ID: 32162688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC).
    Jacobs MF; Stoffel EM
    Fam Cancer; 2024 Aug; 23(3):221-232. PubMed ID: 38573398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer.
    Bogdanski AM; van Hooft JE; Boekestijn B; Bonsing BA; Wasser MNJM; Klatte DCF; van Leerdam ME
    Fam Cancer; 2024 Aug; 23(3):323-339. PubMed ID: 38619782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
    Klein AP
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):493-502. PubMed ID: 34002083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Approaches to Pancreatic Cancer Screening.
    Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
    Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographics and epidemiology of pancreatic cancer.
    Yeo TP; Lowenfels AB
    Cancer J; 2012; 18(6):477-84. PubMed ID: 23187833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.